Eiji Sugiyama

Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders

Y Masaki, Lei Dong, Nobuyuki Kurose et al. · Annals of the Rheumatic Diseases · 2008 · 582 citations

Multicenter Prospective Study of the Efficacy and Safety of Combined Immunosuppressive Therapy With High‐Dose Glucocorticoid, Tacrolimus, and Cyclophosphamide in Interstitial Lung Diseases Accompanied by Anti–Melanoma Differentiation–Associated Gene 5–Positive Dermatomyositis

Hideaki Tsuji, Ran Nakashima, Yuji Hosono et al. · Arthritis & Rheumatology · 2019 · 344 citations · Full text

Identification of defects in glycosylphosphatidylinositol anchor biosynthesis in the Thy-1 expression mutants

Eiji Sugiyama, R DeGasperi, Masaharu Urakaze et al. · Journal of Biological Chemistry · 1991 · 139 citations · Full text

Glycosylphosphatidylinositol Anchor Biosynthesis, Glycobiology, Molecular Biology +18

Wwp2 maintains cartilage homeostasis through regulation of Adamts5

Sho Mokuda, Ryo Nakamichi, Tokio Matsuzaki et al. · Nature Communications · 2019 · 119 citations · Full text

Immunology, Bone Repair, Cellular Physiology +18

Interleukin-10 inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos and c-Jun in RAW264.7 cells and mouse bone marrow cells

Saad Gad-Kamel Mohamed, Eiji Sugiyama, Kouichiro Shinoda et al. · Bone · 2007 · 114 citations

Inflammation, Cytokine, Autoimmune Disease +10